On August 16, 2016 INoPSU held its 9th Scientific and Executive Committee meeting at .. read more
Congratulations to the BPSU on their 30th Anniversary For more on this story please cl.. read more
The network was formed in August 1998 at a meeting of the 10 units expressing a desire to link with each other. This took place at the 22nd International Congress of Paediatrics in Amsterdam, The Netherlands. The first INoPSU conference was held in June 2000 in Canada and was attended by representatives of the existing units.
A document known as the Amsterdam-Ottawa Note detailing the functions and structure of the network was agreed. Click here for the Amsterdam-Ottawa Note (PDF file 155KB).
The mission of INoPSU is the advancement of knowledge of uncommon childhood infections and disorders and the participation of paediatricians in surveillance on a national and international basis so as to achieve a series of benefits.
The mission of this website is to collect information about the advancement of knowledge of uncommon childhood infections and disorders, aiming to facilitate sharing information and collaboration between researchers from different nations and scientific disciplines.
The terms of reference of the organisation were re-written following the 9th INoPSU business meeting in Vancouver.
INoPSU Terms of reference - Vancouver 2016 (PDF, 353KB)
Currently INoPSU does not receive any funding. Each individual national unit has their own source of funding. A small amount of which is put aside to help develop INoPSU activities.
The principle of 'active' surveillance is that initiation for notification comes from the unit rather than the clinician. Active surveillance results in considerably higher case ascertainment than passive surveillance and minimises recall bias. The methodology varies slightly between units to suit local conditions.
In principle, the surveillance unit sends a monthly report card to the 'mailing list' of paediatricians and asks them simply to indicate whether they have 'nothing to report' or to mark the number of new cases of each condition listed that they have seen in the previous month.
Cards are returned to the unit. The individual or organisation responsible for a study (the 'investigator') is notified of positive case reports and given contact details of the reporting clinician. The investigator is then responsible for obtaining clinical and epidemiological data from reporting doctors by postal questionnaire and is for collation, analysis, presentation and publication of data and feedback to the unit's secretariat. Alternative data sources may be used to validate ascertainment. In most countries data collection is anonymous, investigators using a patient code and having no direct access to information that would allow them to identify or contact patients or their families.
Some units use a reply-paid report card and in Australia e-mail reporting was introduced in 1997. Telephone and facsimile reporting is requested for some studies where a timely report is required e.g. to facilitate obtaining biological specimens. On receipt of a case notification one unit (NZPSU) sends study questionnaires directly to the notifying clinician, rather than sending the notifying doctor's details to the investigator, in an attempt to make receipt of questionnaires more timely. In 2003, the return rate of the the monthly cards to units ranged from 73 - 98% and of questionnaires from 47 - 100%.
Workload for the majority of clinicians participating in national surveillance of rare diseases is low. In any single year a large proportion of the mailing list do not report a single case and therefore are not required to complete a questionnaire requesting further details.